Eurobio Scientific Société anonyme (ALERS.PA)
EUR 23.8
(-5.93%)
EUR 23.8
(-5.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.3 Million | 41.84 Million | 65.46 Million | 54.31 Million | 4.99 Million | -523 Thousand |
| Net Income | 4.83 Million | 24.93 Million | 60.54 Million | 73.48 Million | 3.15 Million | -2.76 Million |
| Depreciation & Amortization | 13.14 Million | 9.52 Million | 7.86 Million | 7.01 Million | 6.36 Million | 3.4 Million |
| Deferred income taxes | -1.78 Million | 1.32 Million | 1.64 Million | 1.52 Million | -3.11 Million | 15 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 8.34 Million | 8.84 Million | -3.66 Million | -28.26 Million | -7.73 Million | -2.13 Million |
| Other non-cash items | 17.34 Million | 8.32 Million | 18.29 Million | 42.5 Million | -4.53 Million | -1.16 Million |
| Investing Cash Flow | -318 Thousand | -141.75 Million | -5.47 Million | -3.98 Million | -4.38 Million | -1.54 Million |
| Investments in PPE | -4.05 Million | -2.83 Million | -1.84 Million | -2.29 Million | -1.59 Million | -1.62 Million |
| Acquisitions | -2.6 Million | -129.63 Million | 100 Thousand | -2.24 Million | -2.24 Million | 144 Thousand |
| Investment purchases | - | -9.28 Million | -3.72 Million | 2.24 Million | -553 Thousand | -62 Thousand |
| Sales/Maturities of investments | 6.34 Million | 138.92 Million | - | 553 Thousand | 2.79 Million | -82 Thousand |
| Other Investing Activities | 8.23 Million | -138.92 Million | 1000.00 | -2.24 Million | -2.79 Million | 82 Thousand |
| Financing Cash Flow | -21.03 Million | 83.53 Million | -23.3 Million | 7.67 Million | -4.01 Million | 1.27 Million |
| Debt repayment | -16.44 Million | -97.44 Million | -14.22 Million | -9.86 Million | -10.23 Million | -7.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.79 Million | -12.23 Million | -6.9 Million | -247 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | 2.99 Million | 835 Thousand |
| Other Financing Activities | -41 Thousand | 193.22 Million | -2.16 Million | 17.78 Million | 3.22 Million | 8.24 Million |
| Accounts receivables | 12.89 Million | 20.84 Million | 2.04 Million | -31.64 Million | -8.17 Million | -284 Thousand |
| Accounts payables | -6.22 Million | -13.13 Million | -2.23 Million | 7.12 Million | 4.91 Million | -2.45 Million |
| Inventory | 2.03 Million | 238 Thousand | -3.29 Million | -3.4 Million | 445 Thousand | -1.85 Million |
| Other working capital | -360 Thousand | 897 Thousand | -178 Thousand | -349 Thousand | -4.91 Million | 2.45 Million |
| Cash at beginning of period | 47.49 Million | 92.91 Million | 65.1 Million | 7.01 Million | 11 Million | 11.79 Million |
| Cash at end of period | 49.29 Million | 47.49 Million | 92.91 Million | 65.1 Million | 7.61 Million | 11 Million |
| Capital Expenditure | -4.05 Million | -2.83 Million | -1.84 Million | -2.29 Million | -1.59 Million | -1.62 Million |
| Effect of forex changes on cash | 147 Thousand | -77 Thousand | 138 Thousand | -60 Thousand | 18 Thousand | 12 Thousand |
| Net cash flow / Change in cash | 1.8 Million | -45.42 Million | 27.81 Million | 58.08 Million | -3.38 Million | -785 Thousand |
| Free Cash Flow | 20.24 Million | 39.01 Million | 63.61 Million | 52.01 Million | 3.39 Million | -2.15 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.99 Million | 4.83 Million | 2.64 Million | 2.19 Million | 24.93 Million | 5.71 Million |
| Depreciation & Amortization | 6.81 Million | 13.14 Million | 5.21 Million | 5.56 Million | 9.52 Million | 5.53 Million |
| Deferred income taxes | -540 Thousand | -1.78 Million | -709 Thousand | -1.07 Million | 1.32 Million | 1.23 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.17 Million | 8.34 Million | 5.74 Million | 2.89 Million | 8.84 Million | 6.25 Million |
| Other non-cash items | 71 Thousand | 17.34 Million | 1.76 Million | 8.86 Million | 8.32 Million | 2.67 Million |
| Investing Cash Flow | -1.44 Million | -318 Thousand | 16.83 Million | -17.15 Million | -141.75 Million | -138.56 Million |
| Investments in PPE | -1.72 Million | -4.05 Million | -1.39 Million | -2.65 Million | -2.83 Million | -2.16 Million |
| Acquisitions | -1.76 Million | -2.6 Million | 13.71 Million | 495 Thousand | -129.63 Million | -127.03 Million |
| Investment purchases | - | - | 18.22 Million | -18.22 Million | -9.28 Million | - |
| Sales/Maturities of investments | 1.9 Million | 6.34 Million | 3.11 Million | 3.23 Million | 138.92 Million | -84 Thousand |
| Other Investing Activities | 2.04 Million | 8.23 Million | 4.51 Million | 3.72 Million | -138.92 Million | -7.09 Million |
| Financing Cash Flow | -8.74 Million | -21.03 Million | -13.98 Million | -8.15 Million | 83.53 Million | 96.81 Million |
| Debt repayment | -7.27 Million | -16.44 Million | -9.37 Million | -7.07 Million | -97.44 Million | -99.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -273 Thousand | -2.79 Million | -2.62 Million | -166 Thousand | -12.23 Million | -1.6 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.19 Million | -41 Thousand | -11.36 Million | -40 Thousand | 193.22 Million | -64 Thousand |
| Accounts receivables | -2.77 Million | 12.89 Million | 1.78 Million | 11.11 Million | 20.84 Million | 14.85 Million |
| Accounts payables | 1.57 Million | -6.22 Million | 5.38 Million | -11.61 Million | -13.13 Million | -11.26 Million |
| Inventory | -1.85 Million | 2.03 Million | -1.19 Million | 3.22 Million | 238 Thousand | 2.62 Million |
| Other working capital | 1.45 Million | -360 Thousand | 5.15 Million | 161 Thousand | 897 Thousand | 34 Thousand |
| Cash at beginning of period | 49.29 Million | 47.49 Million | 70.74 Million | 47.49 Million | 92.91 Million | 95.86 Million |
| Cash at end of period | 86.59 Million | 49.29 Million | 49.29 Million | 41.5 Million | 47.49 Million | 47.49 Million |
| Capital Expenditure | -1.72 Million | -4.05 Million | -1.39 Million | -2.65 Million | -2.83 Million | -2.16 Million |
| Effect of forex changes on cash | 36 Thousand | 147 Thousand | 68 Thousand | 79 Thousand | -77 Thousand | -126 Thousand |
| Net cash flow / Change in cash | 37.29 Million | 1.8 Million | -21.45 Million | -5.98 Million | -45.42 Million | -48.36 Million |
| Free Cash Flow | 5.98 Million | 20.24 Million | 13.96 Million | 7.38 Million | 39.01 Million | 14.4 Million |
3847
AMTB
3968
VMSI
3666
3601